A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology-Reference-Cited by-同舟云学术

A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: A new paradigm for clinical outcomes studies in nephrology

Published:2009-07 Issue:3 Volume:13 Page:360-362
ISSN:1492-7535
Container-title:Hemodialysis International
language:en
Short-container-title:

Author:

BLOCK Geoffrey A.,PERSKY Martha S.,KETTELER Markus,KESTENBAUM Bryan,THADHANI Ravi,KOOIENGA Laura,SPIEGEL David,ASPLIN John,EHRLICH James,DENNIS Vincent,NISSENSON Allen,CHERTOW Glenn M.,WHEELER David C.

Publisher

Wiley

Subject

Nephrology,Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1542-4758.2009.00387.x/fullpdf

Reference11 articles.

1. 1 Block GA , Raggi P , Bellasi A , et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007; 71:438-441.

2. 2 Suki WN , Zabaneh R , Cangiano JL , et al. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Kidney Int. 2007; 72:1130-1137.

3. 3 Giachelli CM. Vascular calcification: In vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol. 2003; 14 (Suppl 4):S300-S304.

4. 4 Shanahan CM. Mechanisms of vascular calcification in renal disease. Clin Nephrol. 2005; 63:146-157.

5. 5 Chertow GM , Raggi P , Chasan-Taber S , et al. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2004; 19:1489-1496.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD;Journal of the American Society of Nephrology;2019-07-05

2. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD);Cochrane Database of Systematic Reviews;2018-08-22

3. Dietary Phosphorus Intake and Cardiotoxicity;Dietary Phosphorus: Health, Nutrition, and Regulatory Aspects;2017-10-02

4. Integral pharmacological management of bone mineral disorders in chronic kidney disease (part I): from treatment of phosphate imbalance to control of PTH and prevention of progression of cardiovascular calcification;Expert Opinion on Pharmacotherapy;2016-05-13

5. Relationships Between Serum and Urine Phosphorus With All-Cause and Cardiovascular Mortality: The Osteoporotic Fractures in Men (MrOS) Study;American Journal of Kidney Diseases;2013-04